1-2 of 2
Catherine Megalakaki
Close
Sort by
Journal Articles

Hypercalcemia Remains an Adverse Prognostic Factor for Newly Diagnosed Patients with Symptomatic Multiple Myeloma in the Era of Novel Anti-Myeloma Therapies, Independently of Age, ISS Stage and Treatment Type: An Analysis of 2129 Patients

Athanasios Zomas, Evangelos Terpos, Eirini Katodritou, Argiris Symeonidis, MD, Sosana Delimpasi, Anastasia Pouli, Theodoros P. Vassilakopoulos, Eurydiki Michalis, Stavroula Giannouli, Zafiris Kartasis, Anna Christoforidou, Kiriaki Kokoviadou, Eleftheria Hatzimichael, Dimitra Gika, Catherine Megalakaki, Maria Papaioannou, Marie-Christine Kyrtsonis, Kostas Konstantopoulos, Meletios A. Dimopoulos, Efstathios Kastritis, MD
Journal: Blood
Blood (2014) 124 (21): 2113.
https://doi.org/10.1182/blood.V124.21.2113.2113
Published: 2014
Journal Articles

Preserved Levels Of Uninvolved Immunoglobulins Are Associated With Better Overall Survival In Patients With Multiple Myeloma Independently Of Disease Burden: A Role For The Immune System?

Meletios A. Dimopoulos, MD, Argiris S. Symeonidis, Flora Zagouri, Anastasia Sioni, Anastasia Pouli, Sosana Delimpasi, Eirini Katodritou, Eurydiki Michalis, Michalis Michael, Eleftheria Hatzimichael, Amalia Vassou, Panagiotis Repousis, Anna Christoforidou, Zafiris Kartasis, Ekaterini Stefanoudaki, Catherine Megalakaki, Stavroula Giannouli, Marie-Christine Kyrtsonis, MD, Kostas Konstantopoulos, Evangelos Terpos, Efstathios Kastritis
Journal: Blood
Blood (2013) 122 (21): 1866.
https://doi.org/10.1182/blood.V122.21.1866.1866
Published: 2013